All patients received a topical NSAID regimen for 3 days before surgery and topical tropicamide 1.0%, cyclopentolate 1.0%, and phenylephrine 2.5% on the day of surgery.1
Real-world evidence
OMIDRIA provides an improved patient experience
OMIDRIA significantly improved postoperative day 1 visual acuity across a wide age range1
Of the 641 eyes of 389 patients who underwent cataract surgery, 260 eyes were administered phenylephrine 1.0%/ketorolac 0.3% and 381 eyes received epinephrine in the irrigation solution intraoperatively.1
Immediate improvement in postoperative visual acuity may be attributed to the anti-inflammatory properties of OMIDRIA.1
Single-center, retrospective case review (N=641)1
OMIDRIA reduces pain during and after surgery
The ketorolac component of intracameral OMIDRIA provides higher concentrations compared to topical drops2,3
Fewer drops are needed for cataract surgery, so there is a less demanding routine for you, your staff, and your patients2
OMIDRIA is easy to integrate into your surgical routine4
Prospective, single-masked, comparative study (N=60)5
All patients received preoperative topical lidocaine gel for anesthesia, administered 2-3 times 15 minutes before surgery.5
At the start of the surgery, all patients received 0.5 mL of intracameral preservative-free lidocaine 1%.5
Prospective, randomized, clinical trials (N=821)6
Preoperative treatments were standardized for all patients and included moxifloxacin 0.5% (Vigamox) treatment for at least 3 days before surgery, mydriatic treatment with topical phenylephrine HCl 2.5% plus tropicamide 1.0% three times in the 30 minutes before surgery, and lidocaine or tetracaine for local anesthesia on the day of surgery.6
REFERENCES: 1. Rosenberg ED, Nattis AS, Alevi D, et al. Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%/ketorolac 0.3% administered during cataract surgery. Clin Ophthalmol. 2018;12:21-28. 2. Visco DM, Bedi R. Effect of intracameral phenylephrine 1.0%–ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery. J Cataract Refract Surg. 2020;46(6):867-872. 3. Donnenfeld ED, Whitaker JS, Jackson MA, Wittpenn J. Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgery. J Cataract Refract Surg. 2017;43(5):597-605. 4. OMIDRIA [package insert]. Bellevue, WA: Rayner Surgical Inc. 2023. 5. Donnenfeld ED, Shojaei RD. Effect of intracameral phenylephrine and ketorolac 1.0%/0.3% on intraoperative pain and opioid use during cataract surgery. Clin Ophthalmol. 2019;13:2143-2150. 6. Hovanesian JA, Sheppard JD, Trattler WB, et al. Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: integrated results from 2 pivotal phase 3 studies. J Cataract Refract Surg. 2015;41:2060-2068.